Global Health

FDA Approves Expanded Use of Smallpox Vaccine for High-Risk Mpox Patients

FDA expands ACAM2000 smallpox vaccine approval for Mpox prevention in high-risk patients, becoming the second U.S.-approved option but with key limitations for immunocompromised individuals.